Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13234
Country/Region: Vietnam
Year: 2018
Main Partner: KNCV Tuberculosis Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $447,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $447,000
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
TB_PREV By Age/Sex (Numerator): <15, Female 2019 26
TB_PREV By Age/Sex (Numerator): <15, Male 2019 26
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 583
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 1,088
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 1,723
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 2,027
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 29
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 29
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 684
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 1,285
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 18,420
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2019 431
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2019 4
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2019 4
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2019 144
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2019 279
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 288
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 288
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2019 6,248
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2019 11,596